Table 1

Relationship between β-catenin expression on TCC and clinicopathological characteristics

Immunohistochemistry β-catenin staining, no. (%)Total
PreservedDiffuseDecreased
Tumor grade 18 (80.0)1 (10.0)1 (10.0)10 (100)
Tumor grade 235 (76.0)4 (8.7)7 (15.3)46 (100)
Tumor grade 318 (72.0)1 (4.0)6 (12.0)25 (100)
Tumor stage <136 (81.8)5 (11.4)3 (6.8)44 (100)
Tumor stage 211 (84.6)02 (15.4)13 (100)
Tumor stage >3a14 (58.0)1 (4.0)9 (38.0)24 (100)
M+b1 (50)01 (50)2 (100)
LN+4 (80)01 (20)5 (100)
Multiple tumorsc21 (58.3)6 (16.7)9 (25.0)36 (100)
Total61 (75.3)6 (7.4)14 (17.3)81 (100)
  • a P = 0.02;χ 2 = 5.3.

  • b M+, metastases to distant organs are present; LN+, lymph node involvement is present.

  • c P = 0.0015;χ 2 = 10.